2024 Budget: FG allocates N200m for indigent cancer patients
The Minister of State for Health, Dr Tunji Alausa, has revealed that the sum of N200m has been allocated for the treatment of cancer patients in the 2024 Appropriation Act, contained in the Cancer Health Fund.
READ ALSO: NAOWA Marks World Cancer Day with Awareness Summit in Abuja
He disclosed this during a media conference to commemorate the 2024 World Cancer Day in Abuja.
The minister noted that, Federal Government had put in N1.3bn into the CHF in the last four years to enhance the treatment of indigent patients.
“Though the fund would not be enough to do what is needed to take care of Nigerians, the ministry was mobilising funds through a sector-wide approach by involving private sector participation.
“That is not what we need to take care of the large burden of the disease that we face. We are working on mobilizing a substantial amount of money from two various pathways.
“The Health Sector Renewal Initiative, the big focus of that is sector-wide approach. This will enable us to mobilise funds and coordinate the current fragmentation we have in our healthcare system.
“We have the Basic Health Care Provision Fund, which is one per cent of the Consolidated Revenue Fund but that is not enough to meet the healthcare needs of our vulnerable group and the people that need it the most.”
The minister added that the ministry would collaborate with development partners to direct funds to where it was needed for better coordination to avoid duplication.
He explained, “As we mobilise some of the funds from our development partners as well as the funds from the BHCPF, we will direct more to Primary Healthcare Centres and the National Health Insurance Authority.
“The move is to enable us to cover all patients as we move into the year, and we are fortunate to have a supplementary budget; we will advocate for more funding to be directed to the healthcare sector.”
Alausa further said that the recently created National Institute for Cancer Research and Treatment had been mandated by law to provide leadership in the area of cancer research and treatment.
The minister gave an assurance that the ministry would continue to provide its oversight and policy direction for the fund.
According to him, the ministry, through the National Primary Healthcare Development Agency is leading the Human Papilloma Virus vaccination for primary prevention of cancer of the cervix.
Alausa added, “It is also carrying out hepatitis immunisation for prevention of liver cancers.
“Vaccination for viral hepatitis has been on the national programme on immunisation, HPV Vaccination was commenced in 2023.
“I, hereby, enjoin parents, opinion leaders and indeed all stakeholders to take advantage of the immunisation programmes. The vaccine is free, very safe and highly efficacious in preventing these cancers.”
The Chief Executive Officer, Partnership for Eradication of Cancer in Africa, Ms Salomey Eferemo, said that the rollout of the HPV vaccine was the best thing that happened to the cancer space and Nigerian women.
She harped on early detection being the secret and the cheapest means recommended by the World Health Organisation for Low-Middle-Income Countries such as Nigeria as the Look and Treat Protocol’ for survival.
Eferemo said, “They should routinise it in Nigeria. If a woman walks into a health centre to test for HPV, they should check her for it, and if she has been checked, she should be given a certificate like COVID-19, stamped and dated.
“With this, we can have data to work with, have a registry to know who has and who does not and who needs to be escalated for treatment and the data collection too will be fine.”
She, however, said that her organisation was seeking approval to introduce a device called Oncosic which was capable of detecting between seven to 11 cancers by one specimen of the blood.
The cancer advocate said the disease would be detected from within the DNA and if there is potential to have any sort of cancer or one was identified, treatment could begin early.
“Some cancers take 20 years to manifest, so why would one wait that long when you can just find out how many cancers you do not have?.
“Oncosic has been validated in Europe and they are bringing it here because it is cheap. Most cancer tests are very expensive but this one may be under 20 dollars.
“They put it under an analyser in the lab and use an Artificial Intelligence algorithm to detect it,” she said.
